BBlogFlow

NDP announces seniors’ health care plan at Victoria stop - Penticton Western News

·Oct 5, 2026
Source: Penticton Western News
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

After watching a few shots at the Victoria Curling Club, NDP leader David Eby, joined by other South Island NDP candidates, laid out a seniors’ health care plan as the campaign trail continues ahead of Oct. 24.

“In terms of health care, though, when I think about groups that are particularly concerned about and interested in the future of health care in the province, it’s the people who helped build this province, the seniors,” he told media. For seniors in our province, they want to know a couple things. Are we going to help them stay out of the hospital? And if they need more support, are they going to be able to get the care that they need?”

This article is an excerpt. To read the full content, visit the original source. Penticton Western News

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·